本頁面由Tiger Trade Technology Pte. Ltd.提供服務

和黃醫藥

12.24
+0.06000.49%
成交量:4.03萬
成交額:49.31萬
市值:21.35億
市盈率:121.25
高:12.29
開:12.18
低:12.16
收:12.18
52周最高:18.30
52周最低:9.77
股本:1.74億
流通股本:1.04億
量比:0.80
換手率:0.04%
股息:- -
股息率:- -
每股收益(TTM):0.1010
每股收益(LYR):2.60
淨資產收益率:1.46%
總資產收益率:-1.24%
市淨率:1.69
市盈率(LYR):4.71

資料載入中...

2020/11/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/07/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/06

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/04/29

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/03

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]